17 alpha-hydroxyprogesterone caproate and Pre-Eclampsia

17 alpha-hydroxyprogesterone caproate has been researched along with Pre-Eclampsia in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (25.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Badawy, ER; Mostafa, SA; Othman, MA; Shaltout, AS; Sobh, AMA	1
Kiprono, LV; Lamarca, B; Martin, J; Moseley, J; Wallace, K	1
Amaral, LM; Cornelius, DC; Harmon, A; LaMarca, B; Martin, JN; Moseley, J	1
el-Kabarity, H; Fawzy, MM; Sammour, MB; Schindler, AE	1

Reviews

1 review(s) available for 17 alpha-hydroxyprogesterone caproate and Pre-Eclampsia

Article	Year
Prevention and treatment of pregnancy-induced hypertension (preeclampsia) with progestogens. The Journal of steroid biochemistry and molecular biology, 2005, Volume: 97, Issue:5 Topics: 17 alpha-Hydroxyprogesterone Caproate; Dydrogesterone; Female; Humans; Hydroxyprogesterones; Hypertension, Pregnancy-Induced; Pre-Eclampsia; Pregnancy; Pregnancy Trimester, Third; Progestins	2005

Trials

1 trial(s) available for 17 alpha-hydroxyprogesterone caproate and Pre-Eclampsia

Article	Year
Effect of 17-Hydroxyprogesterone Caproate on Interleukin-6 and Tumor necrosis factor-alpha in expectantly managed early-onset preeclampsia. The Egyptian journal of immunology, 2023, Volume: 30, Issue:2 Topics: 17 alpha-Hydroxyprogesterone Caproate; 17-alpha-Hydroxyprogesterone; Female; Humans; Infant, Newborn; Interleukin-6; Pre-Eclampsia; Pregnancy; Tumor Necrosis Factor-alpha	2023

Other Studies

2 other study(ies) available for 17 alpha-hydroxyprogesterone caproate and Pre-Eclampsia

Article	Year
Progesterone blunts vascular endothelial cell secretion of endothelin-1 in response to placental ischemia. American journal of obstetrics and gynecology, 2013, Volume: 209, Issue:1 Topics: 17 alpha-Hydroxyprogesterone Caproate; Animals; Disease Models, Animal; Endothelial Cells; Endothelin-1; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hydroxyprogesterones; Hypertension; Ischemia; Placenta; Placental Circulation; Pre-Eclampsia; Pregnancy; Progesterone; Progestins; Rats; Rats, Sprague-Dawley	2013
17-hydroxyprogesterone caproate significantly improves clinical characteristics of preeclampsia in the reduced uterine perfusion pressure rat model. Hypertension (Dallas, Tex. : 1979), 2015, Volume: 65, Issue:1 Topics: 17 alpha-Hydroxyprogesterone Caproate; Animals; Blood Pressure; Disease Models, Animal; Estrogen Antagonists; Female; Hydroxyprogesterones; Placenta; Pre-Eclampsia; Pregnancy; Pregnancy, Animal; Progesterone Congeners; Rats; Rats, Sprague-Dawley; Treatment Outcome; Uterine Artery; Vascular Resistance; Vasodilation	2015

Article

Year

Progesterone blunts vascular endothelial cell secretion of endothelin-1 in response to placental ischemia.

American journal of obstetrics and gynecology, 2013, Volume: 209, Issue:1

Topics: 17 alpha-Hydroxyprogesterone Caproate; Animals; Disease Models, Animal; Endothelial Cells; Endothelin-1; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hydroxyprogesterones; Hypertension; Ischemia; Placenta; Placental Circulation; Pre-Eclampsia; Pregnancy; Progesterone; Progestins; Rats; Rats, Sprague-Dawley

2013

17-hydroxyprogesterone caproate significantly improves clinical characteristics of preeclampsia in the reduced uterine perfusion pressure rat model.

Hypertension (Dallas, Tex. : 1979), 2015, Volume: 65, Issue:1

Topics: 17 alpha-Hydroxyprogesterone Caproate; Animals; Blood Pressure; Disease Models, Animal; Estrogen Antagonists; Female; Hydroxyprogesterones; Placenta; Pre-Eclampsia; Pregnancy; Pregnancy, Animal; Progesterone Congeners; Rats; Rats, Sprague-Dawley; Treatment Outcome; Uterine Artery; Vascular Resistance; Vasodilation

2015